Aphria Inc. buy Traumtanz
Start price
11.01.21
/
70%
€7.48
Target price
11.01.22
-
Performance (%)
39.14%
End price
15.01.21
€10.41
Summary
This prediction ended on 15.01.21 with a price of €10.41. With a performance of 39.14% the BUY prediction by Traumtanz was a big success. Traumtanz has 70% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Aphria Inc. | - | - | - | - |
iShares Core DAX® | -1.114% | 5.062% | 24.922% | 25.215% |
iShares Nasdaq 100 | 1.816% | 9.828% | 29.548% | 44.324% |
iShares Nikkei 225® | 2.113% | 8.218% | 22.231% | 12.395% |
iShares S&P 500 | 2.038% | 7.448% | 30.358% | 43.899% |
According to Traumtanz what are the pros and cons of Aphria Inc. for the foreseeable future?
Pros
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Innovative
Some uniques
Top 10 in its market
Differentiated customer and product portfolio
Higher EBIT margin than peer group
Could be worthwhile Investment >10% per year
Fair valuation
positive Cash Flow expected
Good rating
Valuable balance sheet
ROE higher than 10% per year
Normal challenges to pay loans and raise capital
Growths faster than the competition
Sustainability is important
Stable Large shareholder and/or long term investor
Medium risks for its business
Small cyclical dependencies
Well known brand
Future proof or reliable business model
Cons
Comments by Traumtanz for this prediction
In the thread Aphria Inc. diskutieren
Buy Aphria Inc.
In the thread Trading Aphria Inc.
Buy beendet
Stopped prediction by Traumtanz for Aphria Inc.
Aphria Inc.
Start price
Target price
Perf. (%)
€12.71
01.03.23
01.03.23
€14.00
-
02.03.23
02.03.23
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Aphria Inc.
Start price
Target price
Perf. (%)
€12.71
21.01.23
21.01.23
-
24.05.24
24.05.24
-
26.01.23
26.01.23
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Aphria Inc.
Start price
Target price
Perf. (%)
€12.71
20.02.22
20.02.22
€13.00
20.02.23
20.02.23
-
17.03.22
17.03.22
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Aphria Inc.
Start price
Target price
Perf. (%)
€16.47
19.03.21
19.03.21
€13.00
19.03.22
19.03.22
-22.87%
20.02.22
20.02.22
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Aphria Inc.
Start price
Target price
Perf. (%)
€13.38
08.03.21
08.03.21
€15.00
13.62%
10.03.21
10.03.21
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Aphria Inc.
Start price
Target price
Perf. (%)
€20.95
10.02.21
10.02.21
€22.00
11.75%
11.02.21
11.02.21
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Aphria Inc.
Start price
Target price
Perf. (%)
€4.90
14.11.20
14.11.20
-
14.11.21
14.11.21
23.24%
27.11.20
27.11.20
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Aphria Inc.
Start price
Target price
Perf. (%)
€4.27
14.07.20
14.07.20
€5.85
05.08.20
05.08.20
-5.09%
05.08.20
05.08.20
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Aphria Inc.
Start price
Target price
Perf. (%)
€3.70
24.05.20
24.05.20
€5.00
26.06.20
26.06.20
-0.54%
26.06.20
26.06.20
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Aphria Inc.
Start price
Target price
Perf. (%)
€7.73
16.04.19
16.04.19
€10.00
17.04.19
17.04.19
-6.47%
17.04.19
17.04.19
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Aphria Inc.
Start price
Target price
Perf. (%)
€8.65
15.02.19
15.02.19
€10.00
13.03.19
13.03.19
-2.31%
13.03.19
13.03.19
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Aphria Inc.
Start price
Target price
Perf. (%)
€6.14
24.01.19
24.01.19
€10.00
05.02.19
05.02.19
63.36%
05.02.19
05.02.19
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Aphria Inc.
Start price
Target price
Perf. (%)
€5.59
11.01.19
11.01.19
€7.00
16.01.19
16.01.19
7.16%
16.01.19
16.01.19
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Aphria Inc.
Start price
Target price
Perf. (%)
€5.02
28.12.18
28.12.18
€7.00
02.01.19
02.01.19
0.00%
02.01.19
02.01.19
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Aphria Inc.
Start price
Target price
Perf. (%)
€5.05
27.12.18
27.12.18
€10.00
27.12.18
27.12.18
-0.99%
27.12.18
27.12.18
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Aphria Inc.
Start price
Target price
Perf. (%)
€10.87
08.10.18
08.10.18
€18.00
17.10.18
17.10.18
14.54%
17.10.18
17.10.18
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Aphria Inc.
Start price
Target price
Perf. (%)
€8.28
24.06.18
24.06.18
€15.00
28.06.18
28.06.18
-8.57%
28.06.18
28.06.18
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Aphria Inc.
Start price
Target price
Perf. (%)
€7.09
06.04.18
06.04.18
€9.00
10.04.18
10.04.18
-15.80%
10.04.18
10.04.18
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected